<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-12-23</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-12-23</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>33</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
IFNÎ³è¯±å¯¼çš„å·¨å™¬ç»†èƒè®°å¿†å¹¶éç”±è¡¨è§‚é—ä¼ æ”¹å˜ç»´æŒï¼Œè€Œæ˜¯ç»†èƒå› å­æœ¬èº«çš„æŒä¹…æ€§ï¼ˆRNA-Seq, ATAC-Seq, CUT&amp;Tagï¼‰ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- <strong>å…ç–«ç»†èƒåŠŸèƒ½ä¸è°ƒæ§</strong>ï¼šç ”ç©¶å·¨å™¬ç»†èƒè®°å¿†æœºåˆ¶ã€NKç»†èƒå¢æ®–ä¸æ•ˆåº”åŠŸèƒ½ã€NKç»†èƒå¯¹EBVæ„ŸæŸ“Bç»†èƒçš„æ€ä¼¤æœºåˆ¶ã€‚<br />
- <strong>ç»†èƒä¿¡å·é€šè·¯ä¸ç–¾ç—…</strong>ï¼šæ¢ç´¢JAK/STAT/miR155HGé€šè·¯åœ¨NKç»†èƒä¸­çš„ä½œç”¨ï¼ŒNFÎºB1ç¼ºä¹ä¸é«“ç³»ç™½è¡€ç—…çš„å…³è”ï¼Œä»¥åŠRESTåœ¨å†…çš®ç»†èƒå¯å¡‘æ€§ä¸åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­çš„ä½œç”¨ã€‚<br />
- <strong>å¾®ç”Ÿç‰©ç»„ä¸å®¿ä¸»äº’ä½œ</strong>ï¼šè§£æç¡çœ å‰¥å¤ºå¯¹HPA-è‚ é“å¾®ç”Ÿç‰©è½´çš„å½±å“åŠå…¶å¯¹æ³ªè…ºç¨³æ€çš„è¯ç†å­¦å’Œå¾®ç”Ÿç‰©å­¦å¹²é¢„ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- <strong>å¤šç»„å­¦è”åˆåˆ†æ</strong>ï¼šç»“åˆRNA-Seqã€ATAC-Seqã€CUT&amp;Tagç­‰æŠ€æœ¯æ·±å…¥è§£æç»†èƒè®°å¿†æœºåˆ¶ã€‚<br />
- <strong>å•ç»†èƒä¸å®åŸºå› ç»„æŠ€æœ¯</strong>ï¼šåº”ç”¨äºç ”ç©¶è„‰ç»œä¸›å·¨å™¬ç»†èƒçš„å‘è‚²èµ·æºå’Œå…ç–«åŠ¨æ€ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
è¥¿ç­ç‰™ç ”ç©¶äººå‘˜å¼€å‘å‡ºæ–°å‹å¼€æºå·¥å…·RNACOREXï¼Œçªç ´æ€§åœ°æ­ç¤ºéšè—åœ¨ç™Œç—‡ä¸­çš„é—ä¼ ç½‘ç»œã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- åˆ†æé©±åŠ¨ç™Œç—‡çš„å¤æ‚åˆ†å­äº’ä½œç½‘ç»œ<br />
- è¯†åˆ«ç™Œç—‡å‘ç”Ÿå‘å±•çš„å…³é”®é—ä¼ è°ƒæ§æœºåˆ¶</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å¼€æºè½¯ä»¶RNACOREXï¼Œé«˜æ•ˆå¤„ç†æµ·é‡åˆ†å­äº’ä½œæ•°æ®ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (32æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE302528 ç¡çœ å‰¥å¤ºå¼•èµ·çš„HPA-è‚ é“å¾®ç”Ÿç‰©è½´å¤±è°ƒï¼šæ³ªè…ºç¨³æ€çš„è¯ç†å­¦å’Œå¾®ç”Ÿç‰©å­¦æŒ½æ•‘</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:micro(b|be|bial|organism)ã€gutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Shenzhen Huang ; Zhijie LiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSleep deprivation (SD) disrupts systemic homeostasis, yet its impact on lacrimal gland integrity through neuroendocrineâ€“microbial pathways remains unclear. Using a male mice SD model, we show that chronic SD activates the hypothalamic-pituitary-adrenal (HPA) axis, elevates corticosterone, alters gut microbiota, and depletes short-chain fatty acids (SCFAs). These alterations coincide with lacrimal gland atrophy, reduced tear secretion, and increased CD4âº/CD8âº T cell infiltration, accompanied by activation of IL-17-associated inflammatory pathways. Pharmacological inhibition of glucocorticoid synthesis with metyrapone preserves lacrimal gland structure and function while attenuating immune activation. Microbiome-directed interventions, including SCFA supplementation and fecal microbiota transplantation, rebalance gut communities, suppress proinflammatory T cell responses, and maintain lacrimal gland homeostasis. Transcriptomic and immunohistochemical analyses further reveal that all three interventions converge on downregulation of IL-17 signaling. Collectively, these findings establish an HPA-gut microbiome-lacrimal gland axis links neuroendocrine stress to microbial dysbiosis and ocular inflammation, and they suggest therapeutic strategies for SD-associated lacrimal gland dysfunction.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302528" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE294918 IFNÎ³ è¯±å¯¼çš„äººç±»å·¨å™¬ç»†èƒè®°å¿†ä¸æ˜¯ç”±è¡¨è§‚é—ä¼ å˜åŒ–ç»´æŒçš„ï¼Œè€Œæ˜¯ç”±ç»†èƒå› å­æœ¬èº«çš„æŒä¹…æ€§ç»´æŒçš„ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcytokineã€RNA-seqã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Vyas Koduvayur ; Noa Harriott ; Quen Cheng ; Aleksandr Gorin ; Alexander HoffmannSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensMacrophages, as key sentinel cells of the innate immune system, can retain memory of prior stimulus exposure. Interferon gamma (IFNÎ³) plays a central role in maintaining trained immunity in vivo and can induce potent memory in macrophages. Such memory is associated with the formation of de novo enhancers that alter gene expression responses to subsequent stimuli. However, how such enhancers are maintained after cytokine exposure remains unclear. We report that durable IFNÎ³-induced enhancers can last for days after cytokine washout, yet the underlying persistence mechanism is not cell-intrinsic. IFNÎ³-treated macrophages continue to exhibit JAK/STAT signaling days after cytokine removal. Blocking IFNÎ³ signaling with a JAK inhibitor or anti-IFNÎ³ neutralizing antibodies after cytokine removal is sufficient to reverse IFNÎ³-induced enhancers and erase the potentiated state of the treated macrophages. Our findings suggest that epigenetic changes in macrophages do not inherently encode innate immune memory or a â€œpotentiatedâ€ macrophage state, but that rather epigenetic changes are themselves dependent on ongoing cytokine signaling. These findings suggest new possibilities for pharmacologic interventions to reverse aberrantly trained immune states associated with pathology.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294918" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE294915 IFNÎ³ è¯±å¯¼çš„äººç±»å·¨å™¬ç»†èƒè®°å¿†ä¸æ˜¯ç”±è¡¨è§‚é—ä¼ å˜åŒ–ç»´æŒçš„ï¼Œè€Œæ˜¯ç”±ç»†èƒå› å­æœ¬èº«çš„æŒä¹…æ€§ç»´æŒçš„ [ATAC-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcytokineã€ATAC-seqã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Vyas Koduvayur ; Noa Harriott ; Quen Cheng ; Aleksandr Gorin ; Alexander HoffmannSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensMacrophages, as key sentinel cells of the innate immune system, can retain memory of prior stimulus exposure. Interferon gamma (IFNÎ³) plays a central role in maintaining trained immunity in vivo and can induce potent memory in macrophages. Such memory is associated with the formation of de novo enhancers that alter gene expression responses to subsequent stimuli. However, how such enhancers are maintained after cytokine exposure remains unclear. We report that durable IFNÎ³-induced enhancers can last for days after cytokine washout, yet the underlying persistence mechanism is not cell-intrinsic. IFNÎ³-treated macrophages continue to exhibit JAK/STAT signaling days after cytokine removal. Blocking IFNÎ³ signaling with a JAK inhibitor or anti-IFNÎ³ neutralizing antibodies after cytokine removal is sufficient to reverse IFNÎ³-induced enhancers and erase the potentiated state of the treated macrophages. Our findings suggest that epigenetic changes in macrophages do not inherently encode innate immune memory or a â€œpotentiatedâ€ macrophage state, but that rather epigenetic changes are themselves dependent on ongoing cytokine signaling. These findings suggest new possibilities for pharmacologic interventions to reverse aberrantly trained immune states associated with pathology.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294915" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>åˆ©ç”¨ RNA æµ‹åºæŠ€æœ¯å¯¹ K562 ä¼Šé©¬æ›¿å°¼è€è¯ç»†èƒä¸­çš„ PLAG1 VC å’Œ KD è¿›è¡Œè½¬å½•ç»„å­¦åˆ†æã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Shashi Kumari ; Dr. Rukmini Govekar ; Dr. Rahul Mojidra ; Dr. Mythreyi NarasimhanSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCML-CP Patients showing resistance to Imatinib, due to Bcr-Abl mechanisms of resistance are treated with 2nd and 3rd generation TKIs but some non-responders shown Bcr-Abl independant mechanism of resistance. We hypothesize that this could be due to activation of novel pathway, or activation of downstream molecules of Bcr-Abl pathway. In this study we have performed Transcriptomics and epigenomics analysis of K562 and KU812 CML-BC cell sensitive and resistant to imatinib, ITGB3 showed high transcript levels, and was also hypomethylated in K562/R cells as compared to sensitive counterparts and showed higher protein levels in both K562 and KU812 resistant cell lines. Previous studies in the lab also showed ITGB1 as a differentiator in proteomic analysis and further on-going studies indicate its role in resistance. ITGB1 was however not modulated at transcriptional level. The protein levels of ITGB3 were significantly increased in resistant cells (K562; KU812: while those of ITGB1 were significantly decreased in resistant cells (K562; KU812. With the known switching of integrins, whether higher expression of ITGB3 had a role in modulating the levels of transcriptionally non-regulated ITGB1 was investigated in K562/S cells with ITGB1 knocked down (KD) protein levels of ITGB3 were upregulated as compared to VC. Similarly, knock down of ITGB3 in K562/R resulted in increased level of ITGB1 protein. These striking results confirmed switching of integrins and explained reduced levels of ITGB1 despite no alteration at genomic or transcriptomic level in resistant cells.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314200" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>GSE295782 è„‰ç»œä¸›å·¨å™¬ç»†èƒçš„å¤šæ ·æ€§å’Œå…ç–«åŠ¨åŠ›å­¦å—ä¸åŒå‘è‚²èµ·æºçš„å½±å“ [scRNA-seq Tgfbr2_cKO]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Khai Nguyen ; Simone Brioschi ; Marco ColonnaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe choroid plexus (ChP) forms a critical interface between the central nervous system and systemic circulation. Despite its importance, the identity and dynamics of resident macrophages remain incompletely understood. Using single-cell RNA sequencing, flow cytometry, lineage tracing, and imaging, we identified three biologically distinct macrophage populations in the homeostatic ChP, defined by expression of CD163, MHCII, or CD9. These subsets arise from different combinations of primitive and definitive hematopoietic waves, occupy distinct anatomical niches, and differentially rely on CSF1 and IL34 for survival. TGFÎ² signaling is required to maintain their phenotype, and deletion of Tgfbr2 in these cells induces phenotypic reprogramming and disrupts the ChP epithelial barrier. During neuroinflammation, ChP macrophages initiate IFN-I responses and secrete chemokines for CD8 T cell recruitment, while microglia mainly express chemokines for B cells. Finally, we identify phenotypically conserved macrophage subsets in the human ChP, suggesting evolutionary preservation of their phenotypic and functional features.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295782" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>GSE294916 IFNÎ³ è¯±å¯¼çš„äººç±»å·¨å™¬ç»†èƒè®°å¿†ä¸æ˜¯ç”±è¡¨è§‚é—ä¼ å˜åŒ–ç»´æŒï¼Œè€Œæ˜¯ç”±ç»†èƒå› å­æœ¬èº«çš„æŒä¹…æ€§ç»´æŒ [CUT&amp;Tag]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcytokineã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Vyas Koduvayur ; Noa Harriott ; Quen Cheng ; Aleksandr Gorin ; Alexander HoffmannSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensMacrophages, as key sentinel cells of the innate immune system, can retain memory of prior stimulus exposure. Interferon gamma (IFNÎ³) plays a central role in maintaining trained immunity in vivo and can induce potent memory in macrophages. Such memory is associated with the formation of de novo enhancers that alter gene expression responses to subsequent stimuli. However, how such enhancers are maintained after cytokine exposure remains unclear. We report that durable IFNÎ³-induced enhancers can last for days after cytokine washout, yet the underlying persistence mechanism is not cell-intrinsic. IFNÎ³-treated macrophages continue to exhibit JAK/STAT signaling days after cytokine removal. Blocking IFNÎ³ signaling with a JAK inhibitor or anti-IFNÎ³ neutralizing antibodies after cytokine removal is sufficient to reverse IFNÎ³-induced enhancers and erase the potentiated state of the treated macrophages. Our findings suggest that epigenetic changes in macrophages do not inherently encode innate immune memory or a â€œpotentiatedâ€ macrophage state, but that rather epigenetic changes are themselves dependent on ongoing cytokine signaling. These findings suggest new possibilities for pharmacologic interventions to reverse aberrantly trained immune states associated with pathology.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294916" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE271592 è„‰ç»œä¸›å·¨å™¬ç»†èƒçš„å¤šæ ·æ€§å’Œå…ç–«åŠ¨åŠ›å­¦å—ä¸åŒå‘è‚²èµ·æºçš„å½±å“ [scRNA-seq ç¨³æ€]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Siling Du ; Alina Ulezko Antonova ; Marco Colonna ; Simone BrioschiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe choroid plexus, responsible for cerebrospinal fluid production, is vital for brain functions. This organ serves as a crucial interface between the central nervous system and systemic circulation and thus faces constant immunological challenges. While resident macrophages within the choroid plexus provide immunosurveillance, their biological characteristics and immune dynamics remain poorly understood. In this study, we extensively examined the phenotype of choroid plexus macrophages using high-throughput single-cell RNA sequencing, flow cytometry, and imaging techniques. Our data unveiled three distinct macrophage populations within the homeostatic choroid plexus expressing either CD163, MHCII, or CD9. These macrophage subsets exhibited differential input from primitive and definitive hematopoietic waves, different spatial location and relied on distinct factors for survival. Upon neuroinflammation, these cells orchestrated IFN responses producing chemokines for effector CD8 T cells, while microglia predominantly expressed chemokines for B cells. Finally, we present evidence of phenotypically conserved macrophage subsets in the human choroid plexus.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271592" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE271590 è„‰ç»œä¸›å·¨å™¬ç»†èƒçš„å¤šæ ·æ€§å’Œå…ç–«åŠ¨åŠ›å­¦å—ä¸åŒå‘è‚²èµ·æºçš„å½±å“ [bulk RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Siling Du ; Alina Ulezko Antonova ; Marco Colonna ; Simone BrioschiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe choroid plexus, responsible for cerebrospinal fluid production, is vital for brain functions. This organ serves as a crucial interface between the central nervous system and systemic circulation and thus faces constant immunological challenges. While resident macrophages within the choroid plexus provide immunosurveillance, their biological characteristics and immune dynamics remain poorly understood. In this study, we extensively examined the phenotype of choroid plexus macrophages using high-throughput single-cell RNA sequencing, flow cytometry, and imaging techniques. Our data unveiled three distinct macrophage populations within the homeostatic choroid plexus expressing either CD163, MHCII, or CD9. These macrophage subsets exhibited differential input from primitive and definitive hematopoietic waves, different spatial location and relied on distinct factors for survival. Upon neuroinflammation, these cells orchestrated IFN responses producing chemokines for effector CD8 T cells, while microglia predominantly expressed chemokines for B cells. Finally, we present evidence of phenotypically conserved macrophage subsets in the human choroid plexus.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271590" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE271316 è„‰ç»œä¸›å·¨å™¬ç»†èƒçš„å¤šæ ·æ€§å’Œå…ç–«åŠ¨åŠ›å­¦å—ä¸åŒå‘è‚²èµ·æºçš„å½±å“ [scRNA-seq LCMV]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Siling Du ; Alina Ulezko Antonova ; Marco Colonna ; Simone BrioschiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe choroid plexus, responsible for cerebrospinal fluid production, is vital for brain functions. This organ serves as a crucial interface between the central nervous system and systemic circulation and thus faces constant immunological challenges. While resident macrophages within the choroid plexus provide immunosurveillance, their biological characteristics and immune dynamics remain poorly understood. In this study, we extensively examined the phenotype of choroid plexus macrophages using high-throughput single-cell RNA sequencing, flow cytometry, and imaging techniques. Our data unveiled three distinct macrophage populations within the homeostatic choroid plexus expressing either CD163, MHCII, or CD9. These macrophage subsets exhibited differential input from primitive and definitive hematopoietic waves, different spatial location and relied on distinct factors for survival. Upon neuroinflammation, these cells orchestrated IFN responses producing chemokines for effector CD8 T cells, while microglia predominantly expressed chemokines for B cells. Finally, we present evidence of phenotypically conserved macrophage subsets in the human choroid plexus.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271316" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE180559 KDM2A å’Œ KDM2B ååŒä¿æŠ¤ä¸€éƒ¨åˆ† CpG å²›å…å— DNA ç”²åŸºåŒ– [ChIP-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šChIP-seqã€methylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yuan Liu ; Ying Liu ; Yunji Zhu ; Yali Xie ; Hu NieSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusIn the mammalian genome, most CpGs are methylated, however, regions of the genome known as CpG islands (CGIs) are largely unmethylated, which are closely associated with modulating gene expression. The KDM2 proteins (KDM2A and KDM2B) are recruited via their ZF-CxxC domains to CGIs and mediate demethylation of H3K36me2 at these regions. However, the mechanism whether and how KDM2 proteins protect CGIs from DNA methylation remains unknown. Here, we report that depletion of each or both KDM2 proteins, or mutation JmjC domains of KDM2 proteins, leads to a modest increase of DNA methylation at CGIs, but a significant increase at CGI shores. Depletion of both KDM2 proteins shows most obvious increase of DNA methylation, indicating that KDM2A and KDM2B cooperatively regulate DNA methylation at CGIs. We further show that DNA methylation in the absence of KDM2 proteins show more obvious increase at a subset of CpG Islands such as non-marked and H3K27me3-only CGIs than other CpG Islands like bivalent and H3K4me3-only CGIs. Taken together, our finding reveals the role for KDM2 proteins in regulating DNA methylation at CGIs, and uncovers the mechanism by which complex chromatin state including histone modifications and CGI binding proteins synergistically protect CGIs from DNA methylation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180559" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 22 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (1æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ä¸€ç§æ–°å·¥å…·æ­£åœ¨æ­ç¤ºç™Œç—‡å†…éƒ¨çš„éšå½¢ç½‘ç»œ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSpanish researchers have created a powerful new open-source tool that helps uncover the hidden genetic networks driving cancer. Called RNACOREX, the software can analyze thousands of molecular interactions at once, revealing how genes communicate inside tumors and how those signals relate to patient survival. Tested across 13 different cancer types using international data, the tool matches the predictive power of advanced AI systemsâ€”while offering something rare in modern analytics: clear, interpretable explanations that help scientists understand why tumors behave the way they do.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251221043216.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>RNA-seq</td>
<td>8</td>
</tr>
<tr>
<td>immune</td>
<td>6</td>
</tr>
<tr>
<td>sequencing</td>
<td>4</td>
</tr>
<tr>
<td>cancer</td>
<td>3</td>
</tr>
<tr>
<td>scRNA</td>
<td>3</td>
</tr>
<tr>
<td>cytokine</td>
<td>3</td>
</tr>
<tr>
<td>epigenetic</td>
<td>3</td>
</tr>
<tr>
<td>methylation</td>
<td>3</td>
</tr>
<tr>
<td>NK cell</td>
<td>2</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>2</td>
</tr>
<tr>
<td>inflammation</td>
<td>1</td>
</tr>
<tr>
<td>pathway</td>
<td>1</td>
</tr>
<tr>
<td>regex:micro(b</td>
<td>be</td>
</tr>
<tr>
<td>gut</td>
<td>1</td>
</tr>
<tr>
<td>regex:gut(-?microbiome)?</td>
<td>1</td>
</tr>
<tr>
<td>leukemia</td>
<td>1</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>1</td>
</tr>
<tr>
<td>spatial</td>
<td>1</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>1</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (22æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290558" target="_blank" rel="noopener noreferrer">GSE290558 ç»˜åˆ¶å¤šç§ç™Œç»†èƒç³»çš„æ–­è£‚ç»„å›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313748" target="_blank" rel="noopener noreferrer">GSE313748 å‰è¥¿ä»–æ»¨è”åˆç™½è›‹ç™½ç´«æ‰é†‡ï¼ŒåŠ æˆ–ä¸åŠ ç»´ç”Ÿç´ Då—ä½“æ¿€åŠ¨å‰‚å¸•ç«‹éª¨åŒ–é†‡æ²»ç–—è½¬ç§»æ€§èƒ°è…ºç™Œï¼šä¸€é¡¹éšæœºã€å¤šè‡‚ã€IæœŸè¯•éªŒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300321" target="_blank" rel="noopener noreferrer">GSE300321 3Dåˆ†å½¢åœ°å½¢å¯å‡è½»ç‚ç—‡å¹¶èµ‹äºˆè‚¾å°çƒè¶³ç»†èƒéŸ§æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307218" target="_blank" rel="noopener noreferrer">GSE307218 æˆˆæ¢…è¾›è‚½çš„ç»†èƒæ¯’æ€§æ˜¯ç”±ç³–é˜è„‚é€”å¾„å’Œè„‚è´¨-èƒ†å›ºé†‡ç›¸äº’ä½œç”¨ä»‹å¯¼çš„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305670" target="_blank" rel="noopener noreferrer">GSE305670 å¯¹åµŒå…¥ä¸åŒåŸºè´¨ä¸­çš„ç¦»ä½“å¾®è‚¿ç˜¤æ¨¡å‹è¿›è¡Œ RNA æµ‹åºï¼Œè¿™äº›æ¨¡å‹ç”±å¯¹ç…§ç»†èƒæˆ– Arpc4 æ•²é™¤ç»†èƒæ„å»ºè€Œæˆã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284423" target="_blank" rel="noopener noreferrer">GSE284423 å¯¹åŒ…å«å¯¹ç…§ç»„æˆ– Arpc4 æ•²é™¤ (KO) PDAC ç»†èƒçš„ç¦»ä½“å¾®è‚¿ç˜¤æ¨¡å‹è¿›è¡Œ RNA-seq åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277650" target="_blank" rel="noopener noreferrer">GSE277650ï¼šé‰´å®šJAK/STAT/miR155HGæ­£åé¦ˆç¯è·¯åœ¨è°ƒæ§NKç»†èƒå¢æ®–å’Œæ•ˆåº”åŠŸèƒ½ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277631" target="_blank" rel="noopener noreferrer">GSE277631 NFÎºB1ç¼ºé™·ä¸Flt3é«“ç³»ç™½è¡€ç—…ç›¸å…³ï¼Œå¹¶é€šè¿‡RelA:p52å’ŒSOD2è¡¨è¾¾å¤±è°ƒå¢å¼ºç»†èƒè‡ªæˆ‘æ›´æ–°èƒ½åŠ›</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314298" target="_blank" rel="noopener noreferrer">GSE314298 NKG2A+ NK ç»†èƒå¯¹ Epstein-Barr ç—…æ¯’æ„ŸæŸ“çš„ B ç»†èƒçš„ç»†èƒæ¯’æ€§æ˜¯é€šè¿‡ NKG2D å’Œ NKp30 æ¿€æ´»å—ä½“ä»‹å¯¼çš„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313825" target="_blank" rel="noopener noreferrer">GSE313825 æ¯ç³»ç¼ºå¤± UBE3A åŸºå› çš„çŒªçš„æ‰¹é‡ RNA æµ‹åº [Pig_CSC_bulkRNAseq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313824" target="_blank" rel="noopener noreferrer">GSE313824 æ¯ç³»ç¼ºå¤± UBE3A åŸºå› çš„çŒªçš„æ‰¹é‡ RNA æµ‹åº [Pig_Cortex_bulkRNAseq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312561" target="_blank" rel="noopener noreferrer">GSE312561 è‚½é…°-tRNAæ°´è§£é…¶2æ˜¯å›´äº§æœŸå¿ƒè‚Œç—…ä¼´æ¯ä½“å¿ƒåŠ›è¡°ç«­çš„é‡è¦è´Ÿè°ƒæ§å› å­ï¼ˆäººå’Œå°é¼ RNAæµ‹åºï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311823" target="_blank" rel="noopener noreferrer">GSE311823 æˆå¹´ç»µç¾Šå°¾éƒ¨èƒšèƒä½ç½®èº«ä»½ç¨‹åºçš„ç»´æŒï¼šæ¥è‡ª HOXB13 ç©ºé—´ RNA è¡¨è¾¾æ¢¯åº¦çš„è¯æ®</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311725" target="_blank" rel="noopener noreferrer">GSE311725 GWAS ç ”ç©¶ç»“æœçš„åŠŸèƒ½è¡¨å¾å‡¸æ˜¾äº† REST åœ¨å†…çš®å¯å¡‘æ€§å’ŒåŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­çš„ä½œç”¨ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306207" target="_blank" rel="noopener noreferrer">GSE306207 RNA-seq åˆ†æäº†å•ç‹¬ä½¿ç”¨ I-BET726 ä»¥åŠ I-BET726 å’Œå¥¥æ²™åˆ©é“‚åºè´¯è”åˆå¤„ç†çš„ A375 ç»†èƒã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295783" target="_blank" rel="noopener noreferrer">GSE295783 è„‰ç»œä¸›å·¨å™¬ç»†èƒçš„å¤šæ ·æ€§å’Œå…ç–«åŠ¨åŠ›å­¦å—ä¸åŒå‘è‚²èµ·æºçš„å½±å“ [CD45_TotalSeq_ICV_injection]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285259" target="_blank" rel="noopener noreferrer">GSE285259 SlMBD5 é€šè¿‡è¡¨è§‚é—ä¼ æŠ‘åˆ¶ç•ªèŒ„èµ¤éœ‰ç´ åˆ†è§£ä»£è°¢åŸºå›  SlGA2ox4 ä¿ƒè¿›ç§å­èŒå‘ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285255" target="_blank" rel="noopener noreferrer">GSE285255 SlMBD5 é€šè¿‡è¡¨è§‚é—ä¼ æŠ‘åˆ¶ç•ªèŒ„èµ¤éœ‰ç´ åˆ†è§£ä»£è°¢åŸºå›  SlGA2ox4 ä¿ƒè¿›ç§å­èŒå‘ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271630" target="_blank" rel="noopener noreferrer">GSE271630 è„‰ç»œä¸›å·¨å™¬ç»†èƒçš„å¤šæ ·æ€§å’Œå…ç–«åŠ¨åŠ›å­¦å—ä¸åŒå‘è‚²èµ·æºçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180570" target="_blank" rel="noopener noreferrer">GSE180570 éäººçµé•¿ç±»åŠ¨ç‰©æ¤å…¥å‰èƒšèƒåŸºå› ç»„å°è®°çš„ç ”ç©¶ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180560" target="_blank" rel="noopener noreferrer">GSE180560 KDM2A å’Œ KDM2B ååŒä¿æŠ¤ä¸€éƒ¨åˆ† CpG å²›å…å— DNA ç”²åŸºåŒ–å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180558" target="_blank" rel="noopener noreferrer">GSE180558 KDM2A å’Œ KDM2B ååŒä¿æŠ¤ä¸€éƒ¨åˆ† CpG å²›å…å— DNA ç”²åŸºåŒ– [RRBS]</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-22 21:37</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>